Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eclipse (ES) vs Injective (INJ) Price & Performance

EclipseTrade
InjectiveTrade

Price performance (Past 24H)

Key statistics

Eclipse vs Injective — how do they compare? Eclipse trades at Rp42.46 (market cap Rp5,78M, Rp38,52M 24h volume), while Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume). The key difference: Injective is far larger — about 1588235.3× Eclipse's market cap, and Eclipse's supply is capped (132,6M / 1B ES (14%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Eclipse for 5 Days and Injective for 36 Days on average.

ESINJ
Market Cap
Rp5,78MRp9,18T
Volume (24h)
Rp38,52MRp1,72T
Circulating Supply
132,6M / 1B ES (14%)100M INJ
Typical Hold Time
5 Days36 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eclipse

Eclipse (ES) is trading at Rp44.792 with a bearish technical signal, showing oversold conditions on short-term RSI but weak momentum per ADX. The token has a low circulating supply of 14% and a 5-day average hold time, indicating limited liquidity. Recent market data shows subdued trading activity amid broader crypto volatility.

Overall outlook is cautious due to bearish momentum and thin liquidity. Key opportunities include potential rebound from oversold levels, but risks include high volatility, low market cap vulnerability, and lack of recent ecosystem updates. Investors should monitor for increased network activity or exchange listings.

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ES
49% Buy51% Sell
Avg holding period · 5 Days
INJ
29% Buy71% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Eclipse

Eclipse is an SVM network built on Ethereum, using the Solana Virtual Machine for execution. It settles transactions on Ethereum and stores data on Celestia.

Read more on ES

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ